Every night, millions of people with sleep disorders struggle to get a good nights rest. One of the most prominent of these disorders is obstructive sleep apnea (OSA), which impacts ones ability to breathe. During the past two decades, the number of adults living with OSA has grown; 25 million people in the United States and an estimated 100 million around the world have obstructive sleep apnea.
Despite its prevalence, eight out of every 10 people with sleep apnea remain undiagnosed, which can lead to serious health issues, including high blood pressure, chronic heart failure, stroke and even death. With these health implications, its critical that people with OSA get diagnosed, receive the proper course of treatment and stay compliant with therapy. Compliance, however, has not always been easy for patients. Some find it difficult to adjust to sleeping with their CPAP equipment, citing challenges with moving around in their sleep or with pressure on their noses and in their airways. These patients tend to abandon their therapy, leaving them susceptible to the serious health effects that come with not complying with treatment.
Fortunately, advancements in sleep technology are paving the way for new CPAP solutions to be more comfortable, personalized and cost effective. With the ability to personalize service for each patient, these connected care technologies help home medical equipment (HME) providers create better patient experiences and engagement, enhance patient care and improve staff experiencesall while reducing the per capita cost of health care by limiting wasted materials, energy, efforts, money and time. Today, many providers are turning to these solutions to help enhance CPAP therapy for OSA patients from initial diagnosis throughout the entire course of treatment at home.
Once a patient is diagnosed with OSA, personalized CPAP solutions can start to play a significant role in a patients adherence to therapy. The selection of a properly fitting and comfortable mask is an incredibly important factor that strongly influences a persons experience, acceptance and long-term use of treatment. Over the years, advances in mask design, materials and construction have and continue to improve mask effectiveness and comfort.
The latest advancement in developing patient-centric CPAP masks is 3D scanning. This new solution offers a precise and personalized mask fitting experience to give providers data-driven guidance that will help support the right mask selection for their patients. Patients and physicians can sometimes find themselves dealing with trial and error as they seek the best sleep mask for a patients specific needs. But with 3D scanning, providers can have the confidence that their mask recommendation is the best option for the patients needs. By improving the patient experience and satisfaction with the appropriate mask, HME providers can guide patients on the right path to long-term therapy adherence.
Technology is not only helping patients in the beginning stages of their CPAP therapy, but also throughout their courses of treatment. In addition to patient-centric technologies that help providers set patients up with personalized care at the time of diagnosis, connected care technologies are helping patients and providers support adherence over time. An increasing number of HME providers are adopting seamless, connected technology that brings them one step closer to improving long-term CPAP adherence: remote monitoring, therapy adjustments and motivational support.
Before connected care, HME providers had limited ability to remotely know how a patient was responding to therapy, if they were using it as prescribed or if something in their environment had changed. This lack of information created inefficiencies and barriers for providers and resulted in patients returning to the hospital time after time. The emergence of connected care solutions started to limit these inefficiencies and readmissions by allowing providers to monitor patients conditions outside of the doctors office or hospital and understand if they were properly adapting to their CPAP therapy at home.
Today, remote patient management solutions allow providers, physicians and payers alike to review patient data through one unified platform, making it easier to make fast, informed clinical decisions for more personalized patient care. This allows providers to focus on the patients who require immediate attention and to troubleshoot issues early on to help increase CPAP therapy compliance and reduce the risk of a user being readmitted into the hospital.
A simple but powerful example of this is a tool that can monitor the use patterns of a sleep apnea patient as they adapt to CPAP therapy. Knowing these nuanced patterns enables better identification of those patients who will most benefit from intervention. This monitoring tool allows HME providers to focus their efforts on patients who will benefit from service, while minimizing unnecessary calls to compliant patients. It leverages a combination of technology and human capital expertise to ensure the best patient experience and care.
Connected care technologies not only allow effective clinician interaction and monitoring but also offer therapy adjustment and patient management or engagement services, which can help motivate patients to stick with their CPAP treatment regimens within the comfort of their own homes. With these insights, patients can track their progress or set reminders to take action, and even receive motivational messages from their physicians. This helps ensure they stay on track and get the most benefit out of their CPAP therapy while on their own.
As the homecare industry shifts toward a value-based care model with a focus on improving patient adherence, providers are waking up to the fact that technology is an important part of the solution to many of the industrys challenges. With the adoption of patient-centric and connected care technologies, providers now have the capability to deliver more effective CPAP therapy management for patients with sleep apnea from the moment they are diagnosedand through their entire course of treatment. As CPAP technology continues to advance, the industry must make sure connected care and personalized medicine are integrated to provide both providers and patients the best possible solutions for the best possible outcomes.
View original post here:
How Technology Is Reshaping CPAP Therapy - HomeCare
- Personalized medicine could transform healthcare - PMC - April 24th, 2025
- Genomic medicine and personalized treatment: a narrative review - April 24th, 2025
- Podcast: Ochre Bios Approach To Precision Medicine In Liver Treatment - insights.citeline.com - April 24th, 2025
- Reinforcement Learning in Personalized Medicine: A Comprehensive Review of Treatment Optimization Strategies - Cureus - April 24th, 2025
- Evolving Biomarkers: Charting the Future of Precision Medicine - MarketScale - April 24th, 2025
- Next Generation Tissue Biomarkers Market Size Report 2030 - Grand View Research - April 24th, 2025
- City of Hope Research on Artificial Intelligence (AI), Precision Medicine, Immunotherapies and Other Topics to be Presented at American Association of... - April 24th, 2025
- What the Newest mRNA Vaccines Could Do Beyond COVID - News-Medical - April 24th, 2025
- Opinion: Where public health ends and personalised medicine begins - Pulse+IT News - April 24th, 2025
- Crohns Disease Treatment Market to Reach $5.9 Billion by 2034, Driven by Biologics & Precision Medicine - Global Banking | Finance | Review - April 24th, 2025
- The Role of High Throughput Screening in Precision Medicine and Market Growth In New Report - WhaTech - April 24th, 2025
- Antiviral Chewing Gum May Prevent Flu and Herpes Transmission - Inside Precision Medicine - April 14th, 2025
- Wisconsin's role in the next advances in health care - BizTimes - April 14th, 2025
- The Future of Pulmonary Fibrosis Management: Precision Medicine, Biomarkers and AI - Managed Healthcare Executive - April 14th, 2025
- Leading Driver In The Jetrea Market 2025: Rise Of Personalized Medicine Fueling Growth - EIN News - March 9th, 2025
- Personalized Medicine Market Overview 2024-2025 & 2030: Oncology, Neurology, and Cardiology Lead Expansion, ext-Generation Sequencing and AI... - March 9th, 2025
- Innovations in core-shell nanoparticles advance drug delivery and precision medicine - Phys.org - March 9th, 2025
- Personalized Medicine: Motivation, Challenges and Progress - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - HealthLeaders Media - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - Fast Company - February 24th, 2025
- Artificial Intelligence (Ai) In Precision Medicine Market to See Robust Growth from USD 2.14 Billion to USD - EIN News - February 24th, 2025
- BMY: 3 Precision Medicine Stocks That Could Transform Healthcare - StockNews.com - February 24th, 2025
- Cracking Cancers Code: How Genetic Testing Is Changing the Treatment Game - geneonline - February 24th, 2025
- Curt Medeiros on Revolutionizing Precision Medicine and Scaling Ovation - Madrona Venture Group - January 6th, 2025
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022